Home/Filings/4/0002001011-24-000062
4//SEC Filing

Davis Todd C 4

Accession 0002001011-24-000062

CIK 0000886163other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 7:44 PM ET

Size

4.7 KB

Accession

0002001011-24-000062

Insider Transaction Report

Form 4
Period: 2024-06-28
Davis Todd C
Director
Transactions
  • Other

    Common Stock

    2024-06-28$60.71/sh+350$21,247120,510 total
Footnotes (1)
  • [F1]These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001392029

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:44 PM ET
Size
4.7 KB